China's HIPI Pharma urges Supreme Court to protect IPR in face of abuse claims
HIPI Pharma Tech, a Chinese supplier of raw materials for pharmaceutical products, has urged the Supreme People's Court to consider protecting its intellectual property rights following a lower-court ruling that the...To view the full article, register now.
Already a subscriber? Click here to view full article